Related Experiment Video

Updated: Jun 20, 2026

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
03:13

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

The potential of TRPV1 agonists for treating ischemia/reperfusion-induced renal injuries

Supratik Rayamajhi1, Tahmeed Contractor, Donna H Wang

  • 1Michigan State University, Cell and Molecular Biology Program, 2240A Biomedical and Physical Science Building, East Lansing, MI 48824-4320, USA.

Current Opinion in Investigational Drugs (London, England : 2000)
|August 26, 2009
PubMed

Insights

Investigational drugs targeting the TRPV1 channel show promise in preventing kidney injury caused by ischemia/reperfusion (I/R). Activating TRPV1 (transient receptor potential vanilloid 1) reduces inflammation and protects kidney tissue from I/R damage.

Area of Science:

  • Nephrology
  • Pharmacology
  • Physiology

Background:

  • Ischemia/reperfusion (I/R) injury is a significant cause of organ damage, leading to increased morbidity and mortality.
  • Pharmacological interventions are sought to prevent and mitigate I/R-induced pathologies.
  • The transient receptor potential vanilloid 1 (TRPV1) channel, expressed in sensory nerves, is an emerging therapeutic target.

Purpose of the Study:

  • To review recent advancements in investigational drugs targeting TRPV1 and its downstream pathways.
  • To explore the potential of TRPV1 modulation for preventing or treating renal I/R injury.
  • To highlight the role of sensory nerve activity in tissue integrity and inflammatory response.

Main Methods:

  • Review of current scientific literature on TRPV1 agonists and renal I/R injury.
  • Analysis of studies investigating the mechanisms of TRPV1-mediated protection.
  • Focus on preclinical and clinical developments of TRPV1-targeting therapeutics.

Main Results:

  • TRPV1 receptor activation by agonists reduces inflammation associated with I/R injury.
  • TRPV1 agonists have shown protective effects in models of renal I/R injury.
  • Modulation of sensory nerve activity by TRPV1 can attenuate local inflammatory responses.

Conclusions:

  • TRPV1 represents a promising molecular target for managing renal I/R injury.
  • Investigational drugs targeting TRPV1 pathways offer potential therapeutic strategies.
  • Further research into TRPV1-based therapies could improve outcomes for patients with I/R-induced kidney damage.

More Related Videos

An Effective Mouse Model of Unilateral Renal Ischemia-Reperfusion Injury05:53

An Effective Mouse Model of Unilateral Renal Ischemia-Reperfusion Injury

Published on: July 15, 2021

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...